Newly prepared bidentate HLA and tridentate Bz-HLA ligands were used to synthesize the novel uranyl mixed ligand [UO2(HLA)(Bz-HLA)] complex with pentagonal bipyramidal geometry. HLA ligand was prepared via the common acylation method, and the Bz-HLA ligand was prepared using the Schiff base reaction of HLA with a benzohydrazide molecule. FTIR, 1H and 13C NMR, SCXRD, molar conductance, and TG-DTA were mainly implemented to examine the structure of produced compounds. The combined covalency effect of complex due to both ligands has been studied, which was discovered to be influenced by the average bond length values on the pentagonal plane, uranyl axial bond lengths, ligand coordination, and donor ability of various atoms. To demonstrate that solvents have no impact on the covalency of the synthesised complex, Sinha's covalency parameters were computed using UV–vis data. DFT calculations were performed in order to validate experimental findings in comparison to theoretical findings, and theoretical bond characteristics were also investigated through the recognition of global index values. Hirshfeld surface analysis was used to examine the crystal strength, energy characteristics and non-covalent surface interactions. Analysis using cyclic voltammetry(CV) shows that the complex is irreversibly reducing. Understanding the Schiff base of acylpyrazolones and their covalency in uranyl complexes allow for the investigation of a wide range of chemical properties and applications.